.png)
Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Read on for what's behind these changes and how to prevent or treat symptoms
The injection site does not impact gastrointestinal side effects
Bengaluru, Karnataka, 27th of February, 2026 : The collaboration brings together Novo Nordisks global GLP-1 leadership and Abbotts strong India footprint, helping more people with type 2 diabetes benefit from modern, evidence-based diabetes therapies Under the agreement, Abbott will commercialize Novo Nordisks semaglutide (Ozempic) under the brand name Extensior Extensior offers powerful HbA1c reduction, weight-loss benefits, and proven risk reduction of cardiovascular and kidney events in people with type 2 diabetes [i] BENGALURU, February 27, 2026 Abbott, the global healthcare leader, today announced a strategic collaboration with Novo Nordisk India to commercialize Extensior for people living with type 2 diabetes
Medications from pharmacies that follow FDA regulations are safer, even if they cost more
US$ 25.99
US$ 28.31
US$ 23.61
US$ 21.27
US$ 23.28
US$ 23.82
US$ 29.86
US$ 27.49
US$ 29.02
US$ 23.94
US$ 28.79
US$ 22.64
US$ 21.12
